Skip to main content
. 2022 Jul 22;3(9):100381. doi: 10.1016/j.jtocrr.2022.100381

Figure 3.

Figure 3

(A) Kaplan-Meier plot of overall survival (date of tissue collection to last contact) of METex14 patients with and without amplification. (B) Kaplan-Meier plot of overall survival (date of tissue collection to last contact) of MET WT patients with and without amplification. (C) Kaplan-Meier plot of overall survival (date of tissue collection to last contact) of MET-amplified patients with and without METex14. (D) Kaplan-Meier plot of overall survival (date of tissue collection to last contact) of non–MET-amplified patients with and without METex14. HR, hazard ratio; CI, confidence interval; METex14, MET exon 14; WT, wild type.